April 29, 2026
2 min watch
COPENHAGEN, Denmark — In this Healio video, Alissa J. Cooper, MD, a thoracic oncologist at Dana-Farber Cancer Institute, discusses research on the effect of low-dose CT screening in a non-risk-based population.
Results of a prospective, interventional study presented at European Lung Cancer Congress showed a significant reduction in lung cancer mortality associated with a one-time low-dose CT screening.
“This is very provocative,” Cooper said. “This really indicates that maybe screening should be even more widely applied than we are performing currently.”
Sources/Disclosures
Source:
Healio Interviews
Reference:
- Li C, et al. Abstract LBA5. Presented at: European Lung Cancer Congress; March 25-28, 2026; Copenhagen, Denmark.
Disclosures:
Cooper reports honoraria from CancerGRACE, IDEOlogy Health, Intellisphere, MedStar Health, MJH Life Sciences and PeerDirect; consulting roles with AbbVie, Amgen, Boehringer Ingelheim, Daiichi Sankyo/AstraZeneca, Gilead Sciences, Novartis and Regeneron; and prior institutional research funding from AbbVie, Amgen, Daiichi Sankyo, Merck, Monte Rosa Therapeutics and Roche.
Ask a clinical question and tap into Healio AI’s knowledge base.
- PubMed, enrolling/recruiting trials, guidelines
- Clinical Guidance, Healio CME, FDA news
- Healio’s exclusive daily news coverage of clinical data
<
Leave a Reply